Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Giulia Cursano

1PUBLICATIONS

13CO-AUTHORS

Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Sep 28, 2023

Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer.

Mariia Ivanova, Francesca Maria Porta, Marianna D'Ercole

Pageof 1

Frequent Collaborators

1 joint publications

Mariia Ivanova

1 joint publications

Francesca Maria Porta

1 joint publications

Marianna D'Ercole

1 joint publications

Carlo Pescia

1 joint publications

Elham Sajjadi

1 joint publications

Elisa De Camilli

1 joint publications

Oriana Pala

1 joint publications

Giovanni Mazzarol

1 joint publications

Konstantinos Venetis

1 joint publications

Elena Guerini-Rocco

Frequent Collaborators

1 joint publications

Mariia Ivanova

1 joint publications

Francesca Maria Porta

1 joint publications

Marianna D'Ercole

1 joint publications

Carlo Pescia

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

See more related videos

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

See more related videos